Related Experiment Video

Updated: Jun 13, 2026

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Cardiac disorders as risk factors for Alzheimer's disease

Tânia Corrêa de Toledo Ferraz Alves1, Luiz Kobuti Ferreira, Mauricio Wajngarten

  • 1Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil. tania alves@hotmail.com

Journal of Alzheimer'S Disease : JAD
|April 24, 2010
PubMed

Insights

Vascular risk factors significantly contribute to late-onset Alzheimer's disease (AD) development. Managing these conditions may offer a new strategy for dementia prevention.

Area of Science:

  • Neuroscience
  • Cardiology
  • Geriatrics

Background:

  • Late-onset Alzheimer's disease (AD) is primarily sporadic, suggesting a complex interplay between genetic and environmental factors.
  • Vascular risk factors, including stroke, hypertension, and diabetes, are increasingly implicated in AD pathogenesis.
  • Understanding these links is crucial for developing effective dementia prevention strategies.

Purpose of the Study:

  • To review the role of cardiovascular risk factors in the development of Alzheimer's disease.
  • To explore the underlying brain mechanisms connecting vascular health and AD pathology.
  • To highlight the potential for modifiable vascular risk factors in dementia prevention.

Main Methods:

  • Literature review focusing on studies investigating vascular risk factors and Alzheimer's disease.
  • Analysis of proposed pathophysiological mechanisms linking cardiovascular dysfunction to AD.
  • Synthesis of current research on the impact of vascular health on cognitive decline.

Main Results:

  • A strong association exists between common vascular risk factors and the onset of non-genetic Alzheimer's disease.
  • These factors may trigger cerebrovascular dysfunction, contributing to AD pathology.
  • The interplay of genetic predisposition and vascular issues likely determines dementia onset.

Conclusions:

  • Cardiovascular risk factors are critical in Alzheimer's disease pathogenesis.
  • Targeting modifiable vascular conditions in early adulthood presents a promising approach for dementia prevention.
  • Further research into these mechanisms can lead to novel therapeutic and preventative interventions.

More Related Videos

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...